Patient P-02004

Synthetic patientMETA-24 · Day 125 · 35–44 · F · baseline S08Steering view · 3D Open companion preview

Therapy response

Favorable

Tolerance

Deteriorating

GI state

Improving

Inflammatory state

Favorable

Nutritional resilience

Improving

Discontinuation risk

10%

Trajectory

Baseline → today → 30-day prediction · hover a day for signals and events

solid = observed · dashed = predicted

Day 0 META-24 started — Baseline state S08

What changed?

Trajectory is tracking the baseline prediction.

Primary contributors, last 14 days

Toxicity+11
Nutritional resilience+10
GI instability-9

What helped?

No interventions yet.

LIFE OS recommendation

No intervention is indicated right now. The trajectory is stable relative to similar patients. See what worked for similar patients.

Daily trackers

Molecule settings

The trackers this program marks as important, last 14 days vs the 14 before.

Active minutes

Wearable

90 min

improving · +11.2 vs previous 14 d

Sleep duration

Wearable

5.9 h

stable · +0.2 vs previous 14 d

Energy level

Daily log

6.9/10

improving · +1.0 vs previous 14 d

Steps

Wearable

9,285

improving · +958 vs previous 14 d

GI burden

Companion

11.6/100

improving · -15.7 vs previous 14 d

Adherence

Companion

91.8 %

stable · -2.3 vs previous 14 d

Sleep quality

Wearable

27.7/100

improving · +4.8 vs previous 14 d

Glucose, CGM daily mean

CGM

131 mg/dL

improving · -8.0 vs previous 14 d

This trajectory is decaying — what would help, what would not

Steering view →

Heading towards restoration · 98 from the failing basin, 12 from restoration.

Would help

No untried action with strong evidence. Compose one from primitives.
More protein
GI -7 next day on high-intake days · n 21

Would not help

Keep ultra-processed low
GI +6.6 next day on high-intake days · n 17
Keep simple carbs low
GI +3.9 next day on high-intake days · n 18
Keep caffeine low
GI +3.4 next day on high-intake days · n 16

State influencers · digestive

Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.

Protein
-7supporter · 95%
Ultra-processed food
+6.6detractor · 95%
Simple carbohydrates
+3.9detractor · 70%
Caffeine
+3.4detractor · 59%
Dietary fat load
+1.6no signal · 30%
Insoluble fibre
-0.5no signal · 15%
Alcohol
+0.5no signal · 15%
Histamine load
+0.1no signal · 15%

Biological layers

Which pathways look influenced, and by which layer of this person's biology.

Pathways under pressure

Inflammatory signalling ↓20
- MicrobiomeBacteroides fragilis expansion
Autonomic recovery ↓20
- WearableShort sleep window
Mucosal barrier integrity ↓10
- WearableSleep 5.9 h, below personal baseline

DNA

Fictional pharmacogenomic panel

CYP2D6 Rapid metabolizer
Expected exposure

Microbiome

Shannon diversity 2.8 · butyrate capacity 59/100

Akkermansia muciniphilaNormal
Faecalibacterium prausnitziiNormal
Bacteroides fragilisHigh
Bifidobacterium longumLow
EnterobacteriaceaeHigh

Wearable, last 14 days

daily evolution fed into the runtime

HRV: 48 ms
Sleep: 6.7 h
Steps: 8,994
Resting HR: 59 bpm

Daily log: GI score 12, nutritional resilience 71, adherence 92.

What this patient sees in NostraAI

The content that steers the trajectory: what to eat, what to do, what to take.

Open companion preview

What to eat

Keep meals regular; three to four moderate portions spaced through the day
Include a cooked vegetable portion with each main meal
Keep fibre steady; no new sources this week
Eat slowly and stop at comfortable fullness — smaller volume, more often

What to do

Log the daily check-in; one line is enough
Keep the current walking rhythm
Protect a 7.5-hour sleep window; screens off 30 minutes before
Keep hydration steady: small amounts through the day rather than large volumes at once

What to take

Take the dose at the same time relative to your evening meal
No additional supplements this week
Fictional demo item: continue vitamin D as before

284 biologically similar trajectories

Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.

Patient	Similarity	Baseline	Intervention	Outcome	Response today
P-02555	45%	S01	AD-05	no change	79
P-02277	42%	S05	AD-05	improved	92
P-02013	53%	S14	BR-03	no change	94
P-02282	50%	S01	BR-03	no change	88
P-02193	36%	S11	CR-01	improved	87
P-02354	30%	S01	CR-01	improved	78
P-02081	47%	S20	DT-01	no change	88
P-02565	40%	S09	DT-01	no change	79
P-02249	38%	S09	DT-01	improved	100
P-02337	36%	S18	DT-01	no change	100
P-02518	30%	S17	DT-01	improved	68
P-02462	29%	S12	DT-01	improved	65